Astute Medical Receives $40,400,000 Series C Funding
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=502bb33f-9c93-4e2c-92b3-9129839e265e&Preview=1 -
Date
6/7/2012 -
Company Name
Astute Medical -
Mailing Address
3550 General Atomics Court MS 02/641 San Diego, CA 92121 -
Company Description
Astute Medical’s mission is to identify and validate protein biomarkers of severe acute disease.Our focus is community and hospital acquired acute conditions that require rapid diagnosis and risk assessment. Our emphasis is on patients who present to the emergency department with acute symptoms and hospitalized patients who are at risk for an acute event. -
Website
http://www.astutemedical.com -
Transaction Type
Venture Equity -
Transaction Amount
$40,400,000 -
Transaction Round
Series C -
Proceeds Purposes
The Company intends to use the proceeds to begin commercializing its first product, as well as to advance and expand its research, development and validation of biomarker-based laboratory tests. -
M&A Terms
-
Venture Investor
MPM Capital -
Venture Investor
Kaiser Permanente Ventures -
Venture Investor
De Novo Ventures -
Venture Investor
Delphi Ventures -
Venture Investor
Domain Associates -
Venture Investor
Johnson & Johnson Development Corporation
